Synthesis and Characterization of Hydrazide-Hydrazone Derivatives of 3-Pyridine Carboxylic Acid as Antimycobacterial Tuberculosis Agents

Author(s):
Hadi AdibiHadi Adibi1,*, Saeed ZakerSaeed Zaker2, 3, Hamid MonkaresiHamid Monkaresi1
1Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, and Pharmaceutical Sciences Research Network, Ministry of Health, Treatment and Medical Education, Tehran, Iran
2Depatrment of Biology and Microbiology, Faculty of Medicine, Islamic Azad University, Parand Branch, Tehran, Iran
3Masoud Laboratory, Department of Mycobacteriology, Tehran, Iran
*Corresponding Author: Corresponding author: Department of Medicinal Chemistry, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, and Pharmaceutical Sciences Research Network, Ministry of Health, Treatment and Medical Education, Tehran, Iran. Email:[email protected]

Journal of Reports in Pharmaceutical Sciences:Vol. 1, issue 1; 60-66
Published online:Mar 28, 2012
Article type:Research Article
Received:Feb 28, 2012
Accepted:Mar 19, 2012
How to Cite:Adibi H, Zaker S, Monkaresi H. Synthesis and Characterization of Hydrazide-Hydrazone Derivatives of 3-Pyridine Carboxylic Acid as Antimycobacterial Tuberculosis Agents. J Rep Pharm Sci. 2012;1(1):e147806. doi:

Abstract

In this study synthesis of nicotinoyl hydrazone derivatives is investigated by introducing the nicotinicacidhydrazidepharmacophore into several molecules and screening for antimycobacterial activity. Benzaldehyde derivatives react with nicotinicacidhydrazideto form nicotinoylhydrazones.The synthesized compounds were screened against M. tuberculosis H37Rv, clinical isolates of M. tuberculosis and MDR clinical isolates of M. tuberculosisusing the proportion test. The minimum inhibitory concentration (MIC) of N'-(4-methylphenyl) nicotinicacidhydrazone and N'-(4-(N,N-dimethyl)phenyl)nicotinicacidhydrazone exhibited activity between 40 and 200μg/mL and could be a good start point to find new lead compounds against M. tuberculosis. 

Copyright

© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

31
Oct
2011

Synthesis and Antimycobacterial Activity of 2-(Phenylthio) benzoylarylhydrazone Derivatives

Ali Almasirad,
Somayeh Samiee-Sadr,
Abbas Shafiee

Almasirad A, Samiee-Sadr S, Shafiee A. Synthesis and Antimycobacterial Activity of 2-(Phenylthio) benzoylarylhydrazone Derivatives. Iran J Pharm Res. 2011;10(4):e126007. doi: https://doi.org/10.22037/ijpr.2011.984

25
Jul
2015

A Study on Antitubercular and Antimicrobial Activity of Isoniazid Derivative

Elham Pahlavani,
Hadi Kargar,
Nahid Sepehri Rad

Pahlavani E, Kargar H, Sepehri Rad N. A Study on Antitubercular and Antimicrobial Activity of Isoniazid Derivative. Zahedan J Res Med Sci. 2015;17(7):-. doi: https://doi.org/10.17795/zjrms1010

31
Oct
2018

Synthesis and Antimicrobial Evaluation of 4H-Pyrans and Schiff Bases Fused 4H-Pyran Derivatives as Inhibitors of Mycobacterium bovis (BCG)

Seyedeh Mahbobeh Mahdavi,
Azizollah Habibi,
Hadi Dolati,
Seyed Mohammad Shahcheragh,
Soroush Sardari,
Parisa Azerang

Mahdavi SM, Habibi A, Dolati H, Shahcheragh SM, Sardari S, et al. Synthesis and Antimicrobial Evaluation of 4H-Pyrans and Schiff Bases Fused 4H-Pyran Derivatives as Inhibitors of Mycobacterium bovis (BCG). Iran J Pharm Res. 2018;17(4):e124859. doi: https://doi.org/10.22037/ijpr.2018.2295

31
Oct
2016

Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety

Maryam Iman,
Asghar Davood,
Mahboubeh Lotfinia,
Golnoush Dehqani,
Soroush Sardari,
Parisa Azerang
,et al.

Iman M, Davood A, Lotfinia M, Dehqani G, Sardari S, et al. Design, Synthesis and Anti-Tubercular Activity of Novel 1, 4-Dihydropyrine-3, 5-Dicarboxamide Containing 4(5)-Chloro-2-Ethyl- 5(4)-Imidazolyl Moiety. Iran J Pharm Res. 2016;15(4):e127510. doi: https://doi.org/10.22037/ijpr.2016.1932

31
Oct
2015

Design, Synthesis and Evaluation of Antitubercular Activity of Novel Dihydropyridine Containing Imidazolyl Substituent

Maryam Iman,
Asghar Davood,
Golnoush Dehqani,
Mahboubeh Lotfinia,
Soroush Sardari,
Parisa Azerang
,et al.

Iman M, Davood A, Dehqani G, Lotfinia M, Sardari S, et al. Design, Synthesis and Evaluation of Antitubercular Activity of Novel Dihydropyridine Containing Imidazolyl Substituent. Iran J Pharm Res. 2015;14(4):e125381. doi: https://doi.org/10.22037/ijpr.2015.1744

Download PDF486.37 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles